The U.S. Food and Drug Administration (FDA) will allow morphine sulfate oral solution to remain on the market, even though it is unapproved. The FDA's move comes in response to protests from hospice workers who say the removal of the liquid morphine solution from market would result in hardship for terminally ill patients and their caregivers. FDA officials say that though the agency remains committed to ensuring that all prescription drugs on the market are FDA approved, they understand they...